DDMAC Review

Launch campaigns, Form FDA-2253 submissions, materials obtained through surveillance activities, and complaints are assigned to the DDMAC reviewer responsible for that drug or product class. Reviewers evaluate whether the materials meet the requirements for advertising or promotional labeling. Complaints follow a slightly different review process.

See Advertising/Labeling Definitions for an understanding of what constitutes prescription drug advertising and promotional labeling.